January 13, 2026
Dr. Christian Hinrichs, an investigator at the National Cancer Institute, shows a patient the difference between his CT scan showing cancerous tumors (R) and a clean scan after treatment (L) in 2018.
SAUL LOEB/AFP/Getty Images

STAT+ | More people are surviving cancer than ever before, according to new report

In a new report, cancer experts said the five-year survival rate across cancer has reached 70% thanks to better screenings and treatments.

By Angus Chen

STAT+ | With a grin — and tight lips — Revolution Medicines’ CEO faces questions about acquisition

At a session of the JPM Healthcare Conference with CEO Mark Goldsmith, Merck as a potential suitor was on many minds.

By Adam Feuerstein

STAT+ | Illumina launches massive cell atlas to fast-track drug discovery

Illumina is launching a Billion Cell Atlas to help drugmakers validate targets and build AI models of cells, a new growth bet for the firm.

By Jonathan Wosen
More around STAT

In case you missed it

  • Investor behind Moderna says U.S. policy is "taking a sledgehammer to our miracle machine," STAT
  • At JPM, doctors’ darling OpenEvidence says it’s pursuing "medical super-intelligence," STAT
  • In China, AI is finding deadly tumors that doctors might miss, New York Times
  • FDA declines to approve Atara's therapy for rare blood cancer, Reuters
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.
Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.
Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser